Browse News
Filter News
Found 30 articles
-
Evotec SE Fiscal Year 2021 Results: 'Setting the Pace' on the Data-Driven R&D Autobahn to Cures
4/12/2022
Evotec SE reported financial results and corporate updates for the fiscal year ended 31 December 2021.
-
Affini-T Expands Board of Directors with Appointments of Michael Varney, Ph.D., and Daniel Faga
4/5/2022
Affini-T Therapeutics, Inc, a biotechnology company unlocking the power of T cells against oncogenic driver mutations, announced the appointments of Michael Varney, Ph.D., and Daniel Faga to its board of directors.
-
Foresite Labs CEO Vikram Bajaj believes that data science will fundamentally transform the life sciences and translate into the development of new therapeutics for various disease states.
-
Such a deep, data-driven approach is enabling precision medicine, in particular, which is expanding from oncology to autoimmune diseases and other conditions.
-
Formerly Esker Therapeutics, a San Francisco-based biotech company, now named Alumis, closed on a $200 million Series B financing round to help advance its precision immunology medicines.
-
BioSpace is proud to present its NextGen Bio “Class of 2022,” a list of up-and-coming life sciences companies in North America that recently launched.
-
BioSpace Announces Top New Biopharma Companies to Watch in 2022
1/5/2022
BioSpace, Inc., the leading life sciences news and careers site, has announced their selections for the industry’s most exciting up-and-coming companies in 2022.
-
The United States has seen companies launching left and right. Check out the top 10 biopharma Series A rounds in the U.S. so far this year.
-
Evotec SE Reports First Half-Year 2021 Results and Corporate Updates
8/11/2021
Evotec SE announced its financial results for the first half-year of 2021.
-
Foresite Labs-incubated company Interline Therapeutics announced Thursday that it had raised $92 million in a financing round co-led by Foresite Capital and ARCH Venture Partners.
-
Interline Therapeutics Launches With $92 Million to Map and Correct Dysfunctional Protein Communities
5/13/2021
Interline Therapeutics, a Foresite Labs incubated company focused on systematically elucidating protein communities to define molecular mechanisms of disease, announced today that the company has raised $92 million.
-
Amerijet Completes IATA's CEIV Pharma Re-Certification
8/7/2020
Amerijet International Airlines has completed its IATA CEIV Pharma re-certification for the handling of temperature-controlled healthcare and life science products.
-
Xtant Medical Announces Results of Special Meeting of Stockholders
2/14/2018
As a result of the approval of all proposals at the Special Meeting, Xtant expects that it will be able to fully execute its previously announced restructuring plan.
-
Eurofins QTA And Q-Interline Announce Collaboration For The Advancement Of Infrared Testing
8/1/2016
-
Andor Launches Zyla 4.2 PLUS sCMOS Camera Featuring >80% QE And Superior Speed
10/13/2015
-
Andor Launches Zyla sCMOS USB 3.0 Cameras With Market Leading Frame Rate Performance
6/12/2014
-
Hamamatsu Photonics Release: Bigger, Faster Images With The Exceptional New ORCA-Flash4.0 LT Gen II Scientific CMOS Camera
1/13/2014
-
Andor Launches Zyla 4.2 – High Quantum Efficiency, Low Noise sCMOS Camera
10/22/2013
-
Andor sCMOS Cameras Exhibit 100 fps in µManager; the Leading Open Source Microscopy Acquisition Software
7/17/2013
-
Andor Launches Advanced Solutions for Simultaneous Multi-Wavelength Imaging
7/12/2012